Peer Review History
| Original SubmissionJanuary 20, 2021 |
|---|
|
PONE-D-21-02147 Impact of essential workers in the context of social distancing for epidemic control PLOS ONE Dear Dr. Milligan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 24 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chiara Poletto Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overview and strengths This study used a compartmental SEIR model to investigate the role that essential workers versus non-essential worker play in spreading SARS-CoV-2 before and after a shelter in place order. The modeling work used an “archetype” framework, where different types of essential works were identified at different risk levels based on whether they were public-facing, not public-facing, or healthcare workers. This was an interesting and novel approach to consider differences in essential worker job functions and how those may affect SARS-CoV-2 spread. Additionally, the writing was clear and concise, and the manuscript was pleasantly easy to read. Major comments -Choices about specific parameter values were not clear to me. For example, for t_IR, why did you choose 5 days if literature estimates ranged from 5 days to 2 weeks? For t_CR, the literature estimate was 10 days, but you chose 7. Why? I think it is necessary to justify these decisions a bit more. Further, given there is such variability in the parameter values from different studies, it would be nice to consider a sweep across plausible values. Are your results sensitive to difference in these values? Or are conclusions robust to differences in parameter values? This seems like an open question that needs to be considered. Also, I couldn’t figure out the actual R0 you considered. I see the different R0’s relative to relative success of SIP, but what does that actually correspond to? -In the figure captions there are varying degrees of context, which makes it a bit hard to know what to expect from the caption. For example, in Figure 3, I was having trouble interpreting the graph (e.g., why one plot had a red line but others did not). Some of that information on how to interpret it was listed in the text (lines 233-237), but it might be nice to have that directly in the caption. On the flip side, for Figure 4, there was a long paragraph explaining both the context of the figure and the conclusions you were drawing from that figure. This was helpful, but it seemed strange when compared to Figure 3. I suggest an intermediary, some context is helpful, but some could be left to the results itself. -I think the archetype aspect of the study is unique and interesting and should be highlighted a bit more. I think the authors should consider a conceptual figure that more concisely describes the different archetypes and gives more examples of each. Where would farmers fall versus factory workers? What are the defining characteristics of each? You could have a figure with icons for different types of workers that might be in each category. Minor comments -Line 190-191: Do these reductions in R0 compare to some meaningful reduction? Percent reduction in R0? Might be good to include a citation here. -Line 190: Does 5% of the population as EWs correspond to some data? At different points in the epidemic, different people were considered “essential,” does this only refer to those that were considered essential at the very beginning of the pandemic? Where would say hair dressers or nail stylists fall in here? They aren’t essential, but they were one of the first to go back to work, and are surely getting exposed a lot. No need to classify every single profession, but just curious how you’re defining the timeline of EW and where the 5% comes from. -Line 206-208: I think it is ok to not take those into account, but perhaps you could speak to (in the discussion maybe) what it would look like if you did take these into account. -Line 256-257: It is not clear to me why this would yield an intuitive exploration of dynamics between and within EWs and nEWs. Could you please add a bit more of an explanation? -Line 265-266: sentence that spans these two lines has a grammatical issue -Figure 2: It is difficult to see the no EWs line. I am also confused about the solid colored lines. Are these individuals in those archetypes that weren’t essential workers? I didn’t realize that was being considered in this analysis. Please clarify and update figure or manuscript text to better explain this. Reviewer #2: Summary Milligan et al. present a simple theoretical analysis of the role different types of idealized workers play in transmission of SARS-CoV-2 while other members of society socially distance. The models are SEIR-type models parameterized with literature values rather than calibrated to data, and so may preclude any specific or quantitative analyses. Nonetheless, the authors are able to establish several general qualitative principles, the manuscript is on the whole well written, enjoyable to read, and easy to follow, and the authors are clear that the model is not intended to provide quantitative predictions. I only have minor concerns, and these pertain mainly to inconsistent and ambiguous use of terminology and two suggests for supplementary figures. It would also be worth updating several aspects of the introduction and discussion to discuss important changes since the initial submission and how these may affect results, particularly relating to widespread mask-wearing and vaccination. See below for specific comments. Abstract • Line 25: you could say ‘transmission model’ or ‘mathematical model’ so it’s clear to the reader that this is not just a conceptual model. Modeling Essential Workers • I think the length of the infectious period for those in critical care is too long, if I am understanding your methodology correctly. It seems like people’s infectiousness peaks early, just before symptom onset, and is very low by 10 days following infection (see e.g. https://www.nature.com/articles/s41467-021-21710-6 or https://www.nature.com/articles/s41591-020-0869-5). This impacts significantly your third model, the HCW one. It might be worth exploring the effect of turning infectiousness off, or reducing it, for part of the critical care compartments, showing the results in the supplementary material, and referring to them in the main text Results section. At the very least you should describe how a different assumption about the infectious period might affect your results for model C in the discussion. • I also think your assumption about latent period might be too long (see the above mentioned references). The incubation period is on average 5 days, but people are infectious several days before that. It could also be worth doing a supplementary figure with a short latent period, or at least discussing what impact it would have. I imagine it would mainly be on the speed with which public facing essential workers come to be the dominant source of transmission in Fig. 4C? • Line 171-173 – why do you make the assumption that half their contacts are with other EWs? Why do you only make this assumption for the non-public facing EWs? • Line 179: I recommend you write ‘contact’ rather than ‘interaction’ here, and in all other places were you use interaction to mean contact, to avoid confusion with statistical interaction. • Fig. 2 might be hard to read for a color-blind person. It might be worth checking that your color-palette is color-blind friendly and if not using a color-palette that is, like viridis. • Line 206, the term ‘rate of infection’ is ambiguous here and it’s not clear what you mean. If I understand you correctly, I think a better term is ‘infection attack rate’ Results • Line 224-225. Sorry if this seems pedantic, but I’m not sure ‘take root’ is a good way to phrase this, as infections are still occurring in the nEW group in your model. Perhaps you could just say ‘those infections lead to little onward transmission in the nEW group, due to SIP’? • Fig. 4C: please describe the acronyms in the legend. In particular, I don’t know what WH means. • Lines 287: do you mean incidence here, or prevalence on line 286? Here and in other places you seem to be using prevalence and incidence interchangeably. Please check all uses of these terms and ensure you are using the correct one each time. • Line 288: Rather than ‘tracks with’, can you say ‘decays at the same rate’, or something like that? Discussion • Could you discuss how widespread mask use among both nEWs and EWs would affect your results? • Could you discuss what implications your results have, if any, on vaccine prioritization? There are also several modeling preprints which attempt to assess prioritization strategies which I think do include EWs – it would be nice to compare your results to theirs here. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523157.2/ https://www.medrxiv.org/content/10.1101/2021.02.23.21252309v1 https://www.medrxiv.org/content/10.1101/2021.03.04.21251264v1 (there may be others – I just did a quick search on google scholar and these were the first that came up). • Line 347, the word ‘different’ is missing ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Impact of essential workers in the context of social distancing for epidemic control PONE-D-21-02147R1 Dear Dr. Milligan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chiara Poletto Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No |
| Formally Accepted |
|
PONE-D-21-02147R1 Impact of essential workers in the context of social distancing for epidemic control Dear Dr. Milligan: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Chiara Poletto Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .